Preoperative Risk Assessment for Patients with Liver Disease

Rush University Medical Center

S. Repking

MAFLD: What Is It?

Houston Methodist

D. Victor

Major Advancements in MASH Management

Rush University Medical Center

S. Janardhan

Best Practices In Managing NAFLD / NASH

MedNews Week

D. Bernstein

Pharmacologic Management of Alcohol Use Disorder

Scripps Health

R. Lee

The Fatty Liver Disease Epidemic

UPMC

M. Klinge

Updates in Management for Patients with Cirrhosis

Duke Health

R. Doshi

Alcoholism is a Mid-brain Disease: Treat it as Such

Houston Methodist

H. Wetsman

New Therapy for Fatty Liver Disease

Washington University in St. Louis

K. Korenblat

Using Resmetirom (THR-β Agonist) in Your Practice for MASH

Scripps Health

J. Gutierrez

Alcohol Use Disorder (2024)

UCSF School of Medicine

T. Defries

Cutting Edge Diagnostics and Treatment for NAFLD

Northwestern Medicine Gastroenterology

M. E. Rinella, L. Van Wagner

MASLD Updates Early 2025

Adrian Lindsey

Fatty Liver Disease: When to Refer?

Yale School of Medicine

NAFLD: Updates in Management

UChicago Medicine

M. E. Rinella

MASLD for the Non-Hepatologist: Insights from ADA Guidelines

Washington University in St. Louis

K. Williams

Caring for the Post Liver Transplant Patient in the Primary Care Set…

University of Colorado Department of Medicine

B. Henderson, M. O'Meara

Updates on Management of NASH

Pennsylvania Society of Gastroenterology

T. Singh

Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD/MASH…

Pennsylvania Society of Gastroenterology

M. Lagarde

Rising Burden of Alcohol Use Disorder: Management and Outcomes

Scripps Health

J. Gutierrez